CD8A and cancer: As CD8+ T-cell abundance predicted inferior overall survival in all, as well as diagnostic, MCL cases, we performed MCL survival analysis by co-analyzing CD8+ T-cell ratios together with the top 10 cancer-associated, upregulated mRNAs or lncRNAs to evaluate the possibility of identifying high-risk MCL cases.